-+ 0.00%
-+ 0.00%
-+ 0.00%

ARS Pharmaceuticals Files Initial Beneficial Ownership Statement for Chief Legal Officer John L. Slebir

PUBT·11/04/2026 22:08:15
ARS Pharmaceuticals Files Initial Beneficial Ownership Statement for Chief Legal Officer John L. Slebir
  • ARS Pharmaceuticals Chief Legal Officer John L. Slebir filed an initial statement of beneficial ownership on Nov. 4, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ARS Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001475990-26-000008), on November 04, 2026, and is solely responsible for the information contained therein.